LT3374B - Sbstituted corticoid-17-alkylcarbonates, process for preparing thereof and pharmaceutical preparations - Google Patents
Sbstituted corticoid-17-alkylcarbonates, process for preparing thereof and pharmaceutical preparations Download PDFInfo
- Publication number
- LT3374B LT3374B LTIP709A LTIP709A LT3374B LT 3374 B LT3374 B LT 3374B LT IP709 A LTIP709 A LT IP709A LT IP709 A LTIP709 A LT IP709A LT 3374 B LT3374 B LT 3374B
- Authority
- LT
- Lithuania
- Prior art keywords
- general formula
- alkyl
- corticoid
- acid
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4025342A DE4025342A1 (de) | 1990-08-10 | 1990-08-10 | In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
LTIP709A LTIP709A (en) | 1995-01-31 |
LT3374B true LT3374B (en) | 1995-08-25 |
Family
ID=6411982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTIP709A LT3374B (en) | 1990-08-10 | 1993-06-25 | Sbstituted corticoid-17-alkylcarbonates, process for preparing thereof and pharmaceutical preparations |
Country Status (22)
Country | Link |
---|---|
US (1) | US5362721A (fi) |
EP (1) | EP0470617A3 (fi) |
JP (1) | JPH0641187A (fi) |
KR (1) | KR920004407A (fi) |
AU (1) | AU646066B2 (fi) |
CA (1) | CA2048841A1 (fi) |
CZ (1) | CZ279875B6 (fi) |
DE (1) | DE4025342A1 (fi) |
EC (1) | ECSP941049A (fi) |
EG (1) | EG19928A (fi) |
FI (1) | FI913775A (fi) |
HU (1) | HU211994B (fi) |
IE (1) | IE912827A1 (fi) |
IL (1) | IL99135A (fi) |
LT (1) | LT3374B (fi) |
LV (1) | LV10459B (fi) |
MX (1) | MX9100613A (fi) |
NO (1) | NO913115L (fi) |
PT (1) | PT98605A (fi) |
RU (1) | RU2060997C1 (fi) |
TW (1) | TW203056B (fi) |
ZA (1) | ZA916291B (fi) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4328819A1 (de) * | 1993-08-27 | 1995-03-02 | Hoechst Ag | Corticosteroid-17-alkylcarbonat-21/0/-Carbonsäure- und Kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
DE4333920A1 (de) | 1993-10-05 | 1995-04-13 | Hoechst Ag | Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
US5981517A (en) * | 1996-05-09 | 1999-11-09 | Soft Drugs, Inc. | Androstene derivatives |
US6759398B2 (en) * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
GB0019172D0 (en) * | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
WO2002012265A1 (en) * | 2000-08-05 | 2002-02-14 | Glaxo Group Limited | 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT |
US6777399B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
SI1383786T1 (sl) | 2001-04-30 | 2009-02-28 | Glaxo Group Ltd | Protivnetni 17.beta-karbotioatestrski derivati androstana s ciklično estrsko skupino na položaju 17.alfa |
ES2307751T3 (es) * | 2001-06-12 | 2008-12-01 | Glaxo Group Limited | Nuevos esteres heterociclicos centi-inflamatorios 17 alfa de derivados 17 beta de carbotioato de androstano. |
US20050175545A1 (en) * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
GB2389530B (en) * | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
US7820642B2 (en) * | 2005-02-04 | 2010-10-26 | The United States Of America As Represented By The Department Of Health And Human Services | Nandrolone 17β-carbonates |
GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
GB0523251D0 (en) * | 2005-11-15 | 2005-12-21 | Glaxo Group Ltd | Novel compounds |
GB0615108D0 (en) * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
UA116622C2 (uk) * | 2011-11-11 | 2018-04-25 | Аллерган, Інк. | Похідні 4-прегенен-11ss-17-21-тріол-3,20-діону для лікування хвороб очей |
WO2023088308A1 (zh) * | 2021-11-16 | 2023-05-25 | 石家庄迪斯凯威医药科技有限公司 | 一种具有抗耐药性的抗菌化合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1668079A1 (de) | 1968-01-18 | 1971-07-22 | Hoechst Ag | Verfahren zur Herstellung von 17alpha,21-Orthcarbonaten von Steroid-derivaten |
EP0004975A2 (de) | 1978-04-25 | 1979-10-31 | Hoechst Aktiengesellschaft | Corticoid-17-Alkylcarbonate, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel gegen Dermatosen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2735110A1 (de) * | 1977-08-04 | 1979-02-15 | Hoechst Ag | Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung |
SE449106B (sv) * | 1980-07-10 | 1987-04-06 | Otsuka Pharma Co Ltd | Steroid med anti-inflammatorisk verkan samt komposition innehallande denna |
AU558725B2 (en) * | 1983-09-07 | 1987-02-05 | Mitsubishi Kasei Corporation | Corticoid derivatives |
-
1990
- 1990-08-10 DE DE4025342A patent/DE4025342A1/de not_active Withdrawn
-
1991
- 1991-02-22 TW TW080101348A patent/TW203056B/zh active
- 1991-08-08 EG EG47991A patent/EG19928A/xx active
- 1991-08-08 PT PT98605A patent/PT98605A/pt not_active Application Discontinuation
- 1991-08-08 RU SU915001317A patent/RU2060997C1/ru active
- 1991-08-08 HU HU912643A patent/HU211994B/hu not_active IP Right Cessation
- 1991-08-08 EP EP19910113338 patent/EP0470617A3/de not_active Ceased
- 1991-08-08 CZ CS912461A patent/CZ279875B6/cs unknown
- 1991-08-08 IL IL9913591A patent/IL99135A/en not_active IP Right Cessation
- 1991-08-08 FI FI913775A patent/FI913775A/fi not_active Application Discontinuation
- 1991-08-09 AU AU82560/91A patent/AU646066B2/en not_active Ceased
- 1991-08-09 MX MX9100613A patent/MX9100613A/es not_active IP Right Cessation
- 1991-08-09 KR KR1019910013758A patent/KR920004407A/ko not_active Application Discontinuation
- 1991-08-09 JP JP3223670A patent/JPH0641187A/ja active Pending
- 1991-08-09 IE IE282791A patent/IE912827A1/en unknown
- 1991-08-09 ZA ZA916291A patent/ZA916291B/xx unknown
- 1991-08-09 NO NO91913115A patent/NO913115L/no unknown
- 1991-08-09 CA CA002048841A patent/CA2048841A1/en not_active Abandoned
-
1993
- 1993-02-08 US US08/015,041 patent/US5362721A/en not_active Expired - Fee Related
- 1993-05-07 LV LVP-93-302A patent/LV10459B/en unknown
- 1993-06-25 LT LTIP709A patent/LT3374B/lt not_active IP Right Cessation
-
1994
- 1994-02-28 EC EC1994001049A patent/ECSP941049A/es unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1668079A1 (de) | 1968-01-18 | 1971-07-22 | Hoechst Ag | Verfahren zur Herstellung von 17alpha,21-Orthcarbonaten von Steroid-derivaten |
EP0004975A2 (de) | 1978-04-25 | 1979-10-31 | Hoechst Aktiengesellschaft | Corticoid-17-Alkylcarbonate, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel gegen Dermatosen |
Also Published As
Publication number | Publication date |
---|---|
LV10459A (lv) | 1995-02-20 |
NO913115L (no) | 1992-02-11 |
NO913115D0 (no) | 1991-08-09 |
IL99135A0 (en) | 1992-07-15 |
LV10459B (en) | 1995-08-20 |
EG19928A (en) | 1996-07-31 |
PT98605A (pt) | 1992-06-30 |
CZ279875B6 (cs) | 1995-07-12 |
AU646066B2 (en) | 1994-02-03 |
HU211994B (en) | 1996-01-29 |
MX9100613A (es) | 1992-04-01 |
IE912827A1 (en) | 1992-02-12 |
HUT59155A (en) | 1992-04-28 |
LTIP709A (en) | 1995-01-31 |
IL99135A (en) | 1995-12-08 |
ECSP941049A (es) | 1994-11-16 |
EP0470617A2 (de) | 1992-02-12 |
EP0470617A3 (en) | 1992-04-01 |
KR920004407A (ko) | 1992-03-27 |
US5362721A (en) | 1994-11-08 |
AU8256091A (en) | 1992-02-13 |
FI913775A (fi) | 1992-02-11 |
FI913775A0 (fi) | 1991-08-08 |
TW203056B (fi) | 1993-04-01 |
ZA916291B (en) | 1992-04-29 |
JPH0641187A (ja) | 1994-02-15 |
HU912643D0 (en) | 1992-01-28 |
CA2048841A1 (en) | 1992-02-11 |
CS246191A3 (en) | 1992-03-18 |
RU2060997C1 (ru) | 1996-05-27 |
DE4025342A1 (de) | 1992-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LT3374B (en) | Sbstituted corticoid-17-alkylcarbonates, process for preparing thereof and pharmaceutical preparations | |
EP1781683B1 (en) | Process for the preparation of 17-vinyl- triflates as intermediates | |
DE2735110A1 (de) | Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung | |
JPH0113719B2 (fi) | ||
JPH0747593B2 (ja) | ラパマイシンのプロドラッグ | |
e Melo et al. | Synthesis of 2-halo-2H-azirines | |
JP3328377B2 (ja) | 11−ケトステロイド誘導体の新製造法 | |
US5508453A (en) | Intermediate for use in the preparation of taurocholanic acids | |
Cid et al. | 1, 3-dipolar cycloadditions of 3, 4, 5, 6-tetrahydropyridine 1-oxide to α, β-unsaturated lactones: stereochemical assignment and conformational analysis of the products | |
DE10221034A1 (de) | 17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln | |
DE68907934T2 (de) | Verfahren zur Herstellung von 4-Demethoxydaunomycinon, das Aglycon von 4-Demethoxydaunorubicin. | |
DE1620735A1 (de) | Azidoverbindungen | |
JPH04297490A (ja) | 17β アルカノイル 3−オキソ−4−アザ−5α−アンドロスト−1−エン類の新規な製造方法 | |
JPS62142197A (ja) | ステロイド類 | |
DE2219601A1 (de) | beta-Lactame und Verfahren zu deren Herstellung | |
SU1047391A3 (ru) | Способ получени производных рифамицина | |
Fetter et al. | The reaction of 2-(tetrazol-5-yl) alkyl ketones and of 2-(tetrazol-5-yl) alkanoic acid derivatives with lead tetraacetate. A novel method of preparation of alk-2-ynyl ketones and alk-2-ynoic acid derivatives | |
JPH07116221B2 (ja) | ウルソデオキシコ−ル酸の製造方法 | |
Salazar et al. | Carbofluorination of pseudoguaianolide sesquiterpenic lactones | |
DE3635820A1 (de) | Vinyloge porphyrine | |
EP0365973B1 (de) | Verfahren zur Herstellung von 4-0-Alkyl-Rhodomycinen | |
JP2894652B2 (ja) | 多環性オレフィンの製造方法 | |
Schneider et al. | Steroids. Part 43. Thermal decomposition of steroidal azidoformates | |
Solo et al. | Effect of C-21 substituents on the elimination of a 17. alpha.-acyloxy group from 17. alpha.-(acyloxy)-20-oxo steroids | |
Suginome et al. | The Transformation of Jervine into 18-Functional Z*-Homo-C-norsteroids. IV." The Transformation of Jervine into (20i2)-18, 20/3-Epoxy-3/3-hydroxy-Hß-ethyletioiervan-lS-one 3-Acetate via (20Д)-18, 20/3-Ероху-3^-hydroxy-12a, 17/3-ethyletiojervan-ll-one 3-Acetate2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM9A | Lapsed patents |
Effective date: 19970625 |